(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 13.36% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.36%.
Caredx's revenue in 2026 is $379,805,000.On average, 11 Wall Street analysts forecast CDNA's revenue for 2026 to be $22,441,977,614, with the lowest CDNA revenue forecast at $20,766,691,002, and the highest CDNA revenue forecast at $23,393,065,122. On average, 10 Wall Street analysts forecast CDNA's revenue for 2027 to be $24,961,821,739, with the lowest CDNA revenue forecast at $22,794,346,061, and the highest CDNA revenue forecast at $26,340,053,556.
In 2028, CDNA is forecast to generate $27,603,048,599 in revenue, with the lowest revenue forecast at $25,680,387,045 and the highest revenue forecast at $29,051,446,807.